|
Glaxo Settlement Pulls Back Curtain On Drug Marketing
NPR (blog) The government alleged that Glaxo promoted Advair, an asthma remedy combining two drugs, for use as a first-choice treatment for just about anybody with asthma. The Food and Drug Administration, concerned about risks, took a much narrower view and … |
View full post on asthma – Google News